Literature DB >> 34346485

Systematic evaluation of transcriptomics-based deconvolution methods and references using thousands of clinical samples.

Brian B Nadel1,2, Meritxell Oliva3, Benjamin L Shou4, Keith Mitchell5, Feiyang Ma1, Dennis J Montoya6, Alice Mouton7,8, Sarah Kim-Hellmuth9,10, Barbara E Stranger11, Matteo Pellegrini1, Serghei Mangul12.   

Abstract

Estimating cell type composition of blood and tissue samples is a biological challenge relevant in both laboratory studies and clinical care. In recent years, a number of computational tools have been developed to estimate cell type abundance using gene expression data. Although these tools use a variety of approaches, they all leverage expression profiles from purified cell types to evaluate the cell type composition within samples. In this study, we compare 12 cell type quantification tools and evaluate their performance while using each of 10 separate reference profiles. Specifically, we have run each tool on over 4000 samples with known cell type proportions, spanning both immune and stromal cell types. A total of 12 of these represent in vitro synthetic mixtures and 300 represent in silico synthetic mixtures prepared using single-cell data. A final 3728 clinical samples have been collected from the Framingham cohort, for which cell populations have been quantified using electrical impedance cell counting. When tools are applied to the Framingham dataset, the tool Estimating the Proportions of Immune and Cancer cells (EPIC) produces the highest correlation, whereas Gene Expression Deconvolution Interactive Tool (GEDIT) produces the lowest error. The best tool for other datasets is varied, but CIBERSORT and GEDIT most consistently produce accurate results. We find that optimal reference depends on the tool used, and report suggested references to be used with each tool. Most tools return results within minutes, but on large datasets runtimes for CIBERSORT can exceed hours or even days. We conclude that deconvolution methods are capable of returning high-quality results, but that proper reference selection is critical.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  benchmarking; cell type deconvolution; cell type quantification; gene expression

Mesh:

Year:  2021        PMID: 34346485      PMCID: PMC8768458          DOI: 10.1093/bib/bbab265

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   13.994


  33 in total

1.  DeconRNASeq: a statistical framework for deconvolution of heterogeneous tissue samples based on mRNA-Seq data.

Authors:  Ting Gong; Joseph D Szustakowski
Journal:  Bioinformatics       Date:  2013-02-21       Impact factor: 6.937

Review 2.  The immune contexture in human tumours: impact on clinical outcome.

Authors:  Wolf Herman Fridman; Franck Pagès; Catherine Sautès-Fridman; Jérôme Galon
Journal:  Nat Rev Cancer       Date:  2012-03-15       Impact factor: 60.716

3.  The prognostic landscape of genes and infiltrating immune cells across human cancers.

Authors:  Andrew J Gentles; Aaron M Newman; Chih Long Liu; Scott V Bratman; Weiguo Feng; Dongkyoon Kim; Viswam S Nair; Yue Xu; Amanda Khuong; Chuong D Hoang; Maximilian Diehn; Robert B West; Sylvia K Plevritis; Ash A Alizadeh
Journal:  Nat Med       Date:  2015-07-20       Impact factor: 53.440

4.  ImmQuant: a user-friendly tool for inferring immune cell-type composition from gene-expression data.

Authors:  Amit Frishberg; Avital Brodt; Yael Steuerman; Irit Gat-Viks
Journal:  Bioinformatics       Date:  2016-08-16       Impact factor: 6.937

5.  xCell: digitally portraying the tissue cellular heterogeneity landscape.

Authors:  Dvir Aran; Zicheng Hu; Atul J Butte
Journal:  Genome Biol       Date:  2017-11-15       Impact factor: 13.583

6.  Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data.

Authors:  Julien Racle; Kaat de Jonge; Petra Baumgaertner; Daniel E Speiser; David Gfeller
Journal:  Elife       Date:  2017-11-13       Impact factor: 8.140

Review 7.  Understanding tumor ecosystems by single-cell sequencing: promises and limitations.

Authors:  Xianwen Ren; Boxi Kang; Zemin Zhang
Journal:  Genome Biol       Date:  2018-12-03       Impact factor: 13.583

Review 8.  Systematic benchmarking of omics computational tools.

Authors:  Serghei Mangul; Lana S Martin; Brian L Hill; Angela Ka-Mei Lam; Margaret G Distler; Alex Zelikovsky; Eleazar Eskin; Jonathan Flint
Journal:  Nat Commun       Date:  2019-03-27       Impact factor: 14.919

9.  Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data.

Authors:  Francesca Finotello; Clemens Mayer; Christina Plattner; Gerhard Laschober; Dietmar Rieder; Hubert Hackl; Anne Krogsdam; Zuzana Loncova; Wilfried Posch; Doris Wilflingseder; Sieghart Sopper; Marieke Ijsselsteijn; Thomas P Brouwer; Douglas Johnson; Yaomin Xu; Yu Wang; Melinda E Sanders; Monica V Estrada; Paula Ericsson-Gonzalez; Pornpimol Charoentong; Justin Balko; Noel Filipe da Cunha Carvalho de Miranda; Zlatko Trajanoski
Journal:  Genome Med       Date:  2019-05-24       Impact factor: 15.266

10.  Author Correction: Benchmarking of cell type deconvolution pipelines for transcriptomics data.

Authors:  Francisco Avila Cobos; José Alquicira-Hernandez; Joseph E Powell; Pieter Mestdagh; Katleen De Preter
Journal:  Nat Commun       Date:  2020-12-02       Impact factor: 14.919

View more
  2 in total

1.  Integrated analysis of an in vivo model of intra-nasal exposure to instilled air pollutants reveals cell-type specific responses in the placenta.

Authors:  Anela Tosevska; Shubhamoy Ghosh; Amit Ganguly; Monica Cappelletti; Suhas G Kallapur; Matteo Pellegrini; Sherin U Devaskar
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

2.  Deconvolution of a Large Cohort of Placental Microarray Data Reveals Clinically Distinct Subtypes of Preeclampsia.

Authors:  Tian Yao; Qiming Liu; Weidong Tian
Journal:  Front Bioeng Biotechnol       Date:  2022-07-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.